Phenothiazines inhibit S100A4 function by inducing protein oligomerization
- 26 April 2010
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (19), 8605-8610
- https://doi.org/10.1073/pnas.0913660107
Abstract
S100A4, a member of the S100 family of Ca(2+)-binding proteins, regulates carcinoma cell motility via interactions with myosin-IIA. Numerous studies indicate that S100A4 is not simply a marker for metastatic disease, but rather has a direct role in metastatic progression. These observations suggest that S100A4 is an excellent target for therapeutic intervention. Using a unique biosensor-based assay, trifluoperazine (TFP) was identified as an inhibitor that disrupts the S100A4/myosin-IIA interaction. To examine the interaction of S100A4 with TFP, we determined the 2.3 A crystal structure of human Ca(2+)-S100A4 bound to TFP. Two TFP molecules bind within the hydrophobic target binding pocket of Ca(2+)-S100A4 with no significant conformational changes observed in the protein upon complex formation. NMR chemical shift perturbations are consistent with the crystal structure and demonstrate that TFP binds to the target binding cleft of S100A4 in solution. Remarkably, TFP binding results in the assembly of five Ca(2+)-S100A4/TFP dimers into a tightly packed pentameric ring. Within each pentamer most of the contacts between S100A4 dimers occurs through the TFP moieties. The Ca(2+)-S100A4/prochlorperazine (PCP) complex exhibits a similar pentameric assembly. Equilibrium sedimentation and cross-linking studies demonstrate the cooperative formation of a similarly sized S100A4/TFP oligomer in solution. Assays examining the ability of TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization. Together these studies support a unique mode of inhibition in which phenothiazines disrupt the S100A4/myosin-IIA interaction by sequestering S100A4 via small molecule-induced oligomerization.This publication has 36 references indexed in Scilit:
- The Crystal Structures of Human S100A12 in Apo Form and in Complex with Zinc: New Insights into S100A12 OligomerisationJournal of Molecular Biology, 2009
- Opposite roles of metastasin (S100A4) in two potentially tumoricidal mechanisms involving human lymphocyte protein Tag7 and Hsp70Proceedings of the National Academy of Sciences of the United States of America, 2009
- Shape Shifting Leads to Small-Molecule Allosteric Drug DiscoveryCell Chemical Biology, 2008
- Structure of Ca2+-Bound S100A4 and Its Interaction with Peptides Derived from Nonmuscle Myosin-IIABiochemistry, 2008
- A Biosensor of S100A4 Metastasis Factor Activation: Inhibitor Screening and Cellular Activation DynamicsBiochemistry, 2007
- Structural and functional insights into RAGE activation by multimeric S100BThe EMBO Journal, 2007
- Inhibiting HIV-1 integrase by shifting its oligomerization equilibriumProceedings of the National Academy of Sciences of the United States of America, 2007
- S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)Biochemical and Biophysical Research Communications, 2004
- Mts1 Regulates the Assembly of Nonmuscle Myosin-IIABiochemistry, 2003
- The CCP4 suite: programs for protein crystallographyActa crystallographica. Section D, Structural biology, 1994